飯塚 啓介 MESHIZUKA Keisuke

ID:9000256831141

Department of Otorhinolaryngology, Japanese Red Cross Society Medical Center (1999年 CiNii収録論文より)

Search authors sharing the same name

Articles:  1-1 of 1

  • Clinical study of leukotriene antagonist ONO-1078 (pranlukast hydrate), on perennial allergic rhinitis:A double-blind, dose finding study ( late phase II study)  [in Japanese]

    OKUDA Minoru , INAMURA Naoki , NAKABAYASHI Seiichiroh , TOGAWA Kiyoshi , OKAMOTO Yoshitaka , MATSUZAKI Zensei , NAKANO Yuichi , NAKAMURA Hideo , TAGUCHI Kiichiroh , ISHIYAMA Tetsuya , MURAKAMI Yoshihiko , UNNO Tokuji , HISAMATSU Ken-ichi , KAMEI Tamio , MUROI Masahiko , KONNO Akiyoshi , YAMAKOSHI Takayuki , YAGI Toshiaki , OHKUBO Kimihiro , TAKIZAWA Ryuta , NOMURA Yasuya , YOSHIMI Kenjiro , WADA Tetsuharu , FUJITANI Satoru , TOMITA Hiroshi , YAMADA Kumiko , YAMAUCHI Yuki , WATANABE Ken-ichi , USUI Nobuo , YUASA Takafumi , WATANABE Mitsuhiro , MESHIZUKA Keisuke , ICHIKAWA Tomoya , INUYAMA Yukio , YAIMA Hiroshi , GOTO Yuichi , NOZUE Michihiko , MUKOUDAKA Hiroyuki , USAMI Atsushi , YANAGITA Noriyuki , KUNO Kayao , BABA Shunkichi , TAKAGI Ippei , KITAO Syunji , MAGUCHI Shiroh , IWATA Shigenobu , NAITO Kensei , IBATA Katsuro , YOKOYAMA Naoki , SAKAKURA Yasuo , UKAI Kotaro , MASUDA Sawako , WATANABE Yukio , NAKAGAWA Hajime , FURUKAWA Mitsuru , KATAURA Akikatsu , SAKUMOTO Makoto , SAITO Hitoshi , MORI Shigehito , MURAKAMI Yasushi , TAKANAKA Hiroshi , OGINO Satoshi , SENBA Osamu , YAMASHITA Toshio , KUBO Nobuo , IKEDA Hiroki , ASAKURA Kohji , IRIFUNE Morihiro , SHIRAISHI Takayuki , BABA Kenji , NAKAGAMI Tetsuhiro , MATSUNAGA Takashi , YAGATA Hirotaka , NARUO Kazuhiko , ENOMOTO Tadao , SHIBANO Akira , IKOMA Hisaaki , TERADA Nobuhisa , SUZUKI Takeo , KOMIYAMA Sohtaroh , TAKEDA Kazuo , ISHIKAWA Takeru , SAMEJIMA Yasuhiro , OGATA Norihisa , MORIMITU Tamotsu , MATSUURA Koji , HORINOUCHI Ken-ichi , OHYAMA Masaru , TAKASAKA Tomonori , SHIMA Tetsuya , NAKASHIMA Mitsuyoshi

    A multi-institution double-blind group-comparison study of ONO-1078 (pranlukast hydrate) was performed at 3 doses to evaluate its efficacy, safety, and optimal dose in patients with perennial nasal al …

    OTOLOGIA FUKUOKA 45(3Supplement1), 299-321, 1999

    J-STAGE 

Page Top